Pharmacokinetics, Immunogenicity, Safety and Tolerability of MEDI3506 in Health Chinese Participants

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects

NCT07057726 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD7503 in Japanese Healthy Participants.

NCT06093542 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects

NCT03905291 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Pharmacokinetics (Movement of Drugs Within the Body), Safety and Tolerability of Brazikumab in Healthy Chinese and White Participants

NCT05033431 ·Status: COMPLETED ·Phase: PHASE1

Phase 1a Study in Healthy Participants

NCT05953506 ·Status: UNKNOWN ·Phase: PHASE1

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.

NCT04958291 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Safety, Tolerability and Pharmacokinetics of ASC42 in Chinese Healthy Subjects

NCT04965337 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses of AZD8566.

NCT00749333 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety and Tolerability of Single and Multiple Ascending Doses of Oral RO7020531 in Chinese Healthy Participants.

NCT03530917 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects

NCT04793204 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study to Evaluate the PK, Safety, and Tolerability of BG00012 in Chinese, Japanese, and Caucasian Healthy Volunteers

NCT01453426 ·Status: COMPLETED ·Phase: PHASE1

A Study of AK3280 in Chinese Healthy Volunteers

NCT04926116 ·Status: COMPLETED ·Phase: PHASE1

Evaluate the Pharmacokinetics, Safety, and Tolerability of Nirsevimab in Healthy Chinese Adults

NCT04840849 ·Status: COMPLETED ·Phase: PHASE1

A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult Participants

NCT05703841 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants

NCT05143905 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy Participants

NCT05107336 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HS-20004 in Healthy Chinese Volunteers

NCT02746302 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants

NCT06311760 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese Subjects

NCT00766012 ·Status: COMPLETED ·Phase: PHASE1

A Study to Examine the Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of TMC435 in Healthy Chinese Participants

NCT02071355 ·Status: COMPLETED ·Phase: PHASE1

A Study of AK0529 to Evaluate Pharmacokinetics and Safety in Chinese Healthy Volunteers

NCT03322800 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ASP1941 in Healthy Male Taiwanese Subjects

NCT01373060 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants

NCT07007546 ·Status: RECRUITING ·Phase: PHASE1

The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Formulation F1) in Healthy Volunteers

NCT06932536 ·Status: COMPLETED ·Phase: PHASE1

An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers

NCT00721448 ·Status: COMPLETED ·Phase: PHASE1